Financial Section 11 5 54 56 58 59 6 63 http://www.santen.co.jp/ja/ir/document/securities.jsp Santen Pharmaceutical Co., Ltd. Annual Report 215 49
4% 215 3 214 3 P.8 2 98.4% 11.1%1,592 62 12.6% 25 69 1.6%1,618 31 11.5%1,525 56 94.3% 3.5%1,53 45 32.1%37 14 8.8%1,36 59 6.1%96 29 215 8 3 5 Santen Pharmaceutical Co., Ltd. Annual Report 215
51 74 68 68 4.1%67 6 13.1%23 27 % 215 3 214 3 159,262 152,556 136,59 9,629 6,868 6,76 2,569 2,327 242 161,831 143,32 136,88 125,33 1,251 1,595 6,44 2,94 2,678 262 146,26 11.1 11.5 8.8 (6.1) 33.6 4.1 (12.6) (13.1) (7.4) 1.6 % 2, 4 1,618 1,463 1,18 1,144 1,191 22.9 1, 16.5 16.6 15.4 16.5 2 2 42 1.7%563 73 4.4 34.8% 17.4%488 93 3.7%174 77 39 79 18.4%353 74 2.4%21.9% % 4 4 354 37 299 267 247 27.7 2 23.4 2.7 2.4 21.9 2 211 212 213 214 215 211 212 213 214 215 Santen Pharmaceutical Co., Ltd. Annual Report 215 51
16.2%7 68 35.5%2 79 118 31 35.1%33.% 28.% 665 628.% 665 6 3,42 ROA 8.9%1,56 72 64.5%49.5% 291 4 844 33 347 25 21.9%24 32 13.5% 14.9%1 EPS 47.78 58.18 1 47.63 57.93 215 4 1 215 4 1 15 214 4 3 1 1 EPS 1 214 3 1 EPS 1 EPS 3 3 249.71 196.96 195.81 24 213 197 15 172 165 15 ROA 3,5 1,988 1,996 1,848 1,75 12.1 ROA % 3 3,42 2,376 15 8.9 8.3 8.9 8.9 211 212 213 214 215 491 91 924 21 4 563 436 81 58.18 47.78 211 212 213 214 215 245 69 2,117 79 78.8%69.6% 1 13.% 58.71 511.14 ROE11.1%12.% 52 Santen Pharmaceutical Co., Ltd. Annual Report 215
ROE 2,5 1,25 ROE % 3 2,118 1,872 1,561 1,645 1,648 14.5 1.7 15 11.1 12. 1. 211 212 213 214 215 253 86253 86 14 87 77 1 24 32 69 58 617 9617 9 41 49 634 68 289 6289 6 82 64 4 6474 659 23 214 217 ROE 13% 4% 1 111 ROE 12.% 1 14 11 1 1 1 9 7 211 212 213 214 215 215 3 214 3 25,386 26,686 (1,3) (61,79) (7,847) (53,862) 28,96 (7,954) 36,914 65,923 72,397 (6,474) Santen Pharmaceutical Co., Ltd. Annual Report 215 53
54 Santen Pharmaceutical Co., Ltd. Annual Report 215 2 215 3 25% PL 215 3 22.9% 54 Santen Pharmaceutical Co., Ltd. Annual Report 215 2 215 3 25% PL 215 3 22.9%
55 Santen Pharmaceutical Co., Ltd. Annual Report 215 17% PL 55 Santen Pharmaceutical Co., Ltd. Annual Report 215 17% PL
3 31 25 26 27 28 : 92,696 98,398 1,486 13,394 33,71 34,535 35,484 36,513 2 4,4 42,868 44,59 46,51 18,982 2,995 2,412 2,371 18,436 2,342 21,39 2,483 7,413 7,319 7,891 7,832 11,23 13,23 13,148 12,651 4,97 2,16 3,556 3,151 4,75 4,824 4,761 4,593 12,62 13,971 13,663 12,942 3 125.85 15.26 151.58 146.15 3 125.71 15.1 151.31 145.94 3 1,249.32 1,368.27 1,481.83 1,494.48 5. 6. 65. 8. : 6,619 2,879 14,959 15,468 (2,97) (1,33) (5,846) (2,83) (12,712) (5,9) (5,691) (11,415) 36.1 218.7 164.3 163.6 14. 26.9 36.4 34.1 139,98 15,458 159,99 156,547 32,676 3,395 3,485 29,849 82,735 93,893 1,82 12,754 18,24 118,637 128,587 126,998 6,882 5,614 5,446 5,278 ROE% 1.4 11.5 1.6 9.9 ROA% 7.6 9. 8.5 8. % 77.3 78.9 8.8 81.1 % 142.3 163. 165.3 126.2 PER 18.3 18.8 2. 15.9 DOE% 4.1 4.6 4.6 5.4 86,659 86,751 86,825 86,867 2,38 2,312 2,49 2,483 1. 215 3 31112.17 2. 3. 215 214 3 1 213 56 Santen Pharmaceutical Co., Ltd. Annual Report 215
1 29 21 211 212 213 214 215 215 11,619 11,594 11,812 114,416 119,66 146,26 161,831 $1,346,68 35,947 34,71 34,437 35,385 41,51 57,353 56,373 469,17 5,178 46,244 45,636 52,299 52,884 41,642 48,893 46,864 15,494 29,64 3,739 26,732 24,681 29,878 35,374 294,369 15,824 28,61 31,74 27,791 25,592 3,361 35,863 298,437 5,71 9,887 9,741 1,63 9,71 1,643 11,831 98,452 1,123 18,723 21,333 17,161 16,521 24,32 199,985 2,953 1,315 1,651 3,281 3,69 5,879 66,44 552,889 4,21 3,421 2,976 2,949 3,291 2,841 6,958 57,899 18,458 14,123 13,221 17,225 16,72 16,862 17,477 145,437 119.8 22.1 249.71 196.96 195.81 47.78 58.18 $.48 118.97 219.85 249.42 196.76 195.51 47.63 57.93.48 1,472.32 1,614.8 1,793.15 1,887.81 1,998.44 452.43 511.14 4.25 8. 8. 9. 1. 1. 1. 11..92 11,849 26,11 17,768 21,483 9,943 26,686 25,386 $ 211,248 (5,619) (829) (7,676) (1,273) (4,596) (7,847) (61,79) (513,514) (11,373) (6,753) (1,57) (8,559) (21,557) (7,954) 28,96 24,988 165.5 558.1 488.5 1,285. 3,37.8 2,855.4 39.8 5.5 2.5 1.1 1.1 1.9.6 146.4 151,12 166,878 184,81 198,81 199,641 237,64 34,2 $2,531,411 28,665 26,574 24,957 25,523 27,42 27,175 29,14 242,188 11,53 118,832 137,668 14,288 132,583 153,241 15,672 1,253,822 125,181 137,343 156,99 164,514 164,88 187,21 211,779 1,762,33 154 75 152 179 145 12 25,351 21,958 8. 14.3 14.5 1.7 1. 11.1 12. 6.6 11.8 12.1 8.9 8.3 8.9 8.9 82.9 82.3 84.5 82.8 82.6 78.8 69.6 154.3 143.1 156.2 155. 183.8 159.2 237.7 23. 12.7 13.3 17.9 22.7 19.2 3.1 5.4 5.2 5.3 5.4 5.1 4.7 4.6 86,916 86,992 87,53 87,147 82,469 82,583 82,653 2,69 2,756 2,867 3,53 3,5 3,72 3,23 Santen Pharmaceutical Co., Ltd. Annual Report 215 57
215 3 31 214 215 215 146,26 (57,353) 88,97 (41,642) (19) (16,862) 681 (1,16) 29,878 916 (433) 3,361 (1,643) 161,831 (56,373) 15,458 (48,893) (3,979) (17,477) 723 (458) 35,374 768 (279) 35,863 (11,831) 24,32 $1,346,68 (469,17) 877,573 (46,864) (33,111) (145,437) 6,19 (3,811) 294,369 6,392 (2,324) 298,437 (98,452) 199,985 463 2,236 33 7,863 2,524 65,442 4,752 27,169 248 32,446 2,6 7,26 27,11 24,32 24,32 199,985 199,985 27,169 27,169 32,446 32,446 27,11 $ 27,11 214 215 47.78 47.63 58.18 57.93 215 $.48.48 58 Santen Pharmaceutical Co., Ltd. Annual Report 215
59 Santen Pharmaceutical Co., Ltd. Annual Report 215 215 $ 242,188 72,614 288,964 24,784 19,39 1,277,589 167,535 513,45 1,552 22,74 548,581 1,253,822 1,253,822 21,958 45,43 12,15 23,914 7,937 3,254 168,57 16,593 55,993 9,962 73,772 468,827 61,439 67,217 (158) 1,488,227 145,65 1,762,33 1,762,33 214 215 27,175 26,61 23,334 5,215 2,65 84,399 213 4 1 27,63 22,65 19,35 5,11 2,234 76,218 29,14 84,433 34,725 2,978 2,288 153,528 19,461 53,986 4,587 2,356 72,397 152,787 454 153,241 2,35 45,324 2,217 2,45 6,237 13,128 414 13,542 2,133 61,71 187 2,728 65,923 15,672 15,672 237,64 26,76 34,2 2,531,411 5,43 38,93 92,421 237,64 26,76 34,2 769,81 $2,531,411 12 5,41 1,467 2,795 1,479 11,244 141 5,966 1,278 2,395 1,7 1,787 25,351 5,459 1,444 2,874 953 36,81 19,72 4,88 8,81 996 6,157 39,186 13,766 5,846 3,168 72 4,634 28,116 2,25 19,298 6,729 1,197 8,866 56,34 7,264 7,959 162,727 9,269 187,21 187,21 7,81 7,776 (2) 15,516 2,486 167,857 167,857 7,383 8,77 (18) 178,84 17,497 211,779 211,779 215 3 31 59 Santen Pharmaceutical Co., Ltd. Annual Report 215 215 $ 242,188 72,614 288,964 24,784 19,39 1,277,589 167,535 513,45 1,552 22,74 548,581 1,253,822 1,253,822 21,958 45,43 12,15 23,914 7,937 3,254 168,57 16,593 55,993 9,962 73,772 468,827 61,439 67,217 (158) 1,488,227 145,65 1,762,33 1,762,33 214 215 27,175 26,61 23,334 5,215 2,65 84,399 213 4 1 27,63 22,65 19,35 5,11 2,234 76,218 29,14 84,433 34,725 2,978 2,288 153,528 19,461 53,986 4,587 2,356 72,397 152,787 454 153,241 2,35 45,324 2,217 2,45 6,237 13,128 414 13,542 2,133 61,71 187 2,728 65,923 15,672 15,672 237,64 26,76 34,2 2,531,411 5,43 38,93 92,421 237,64 26,76 34,2 769,81 $2,531,411 12 5,41 1,467 2,795 1,479 11,244 141 5,966 1,278 2,395 1,7 1,787 25,351 5,459 1,444 2,874 953 36,81 19,72 4,88 8,81 996 6,157 39,186 13,766 5,846 3,168 72 4,634 28,116 2,25 19,298 6,729 1,197 8,866 56,34 7,264 7,959 162,727 9,269 187,21 187,21 7,81 7,776 (2) 15,516 2,486 167,857 167,857 7,383 8,77 (18) 178,84 17,497 211,779 211,779 215 3 31
6 Santen Pharmaceutical Co., Ltd. Annual Report 215 7,81 7,776 (2) 463 463 15,516 2,162 2,236 2,236 183 183 7,959 (7) (7) (8,25) 743 (7,57) 162,727 (463) (463) (28) (28) 4,118 4,752 4,752 324 2,486 167,857 27,169 167,857 27,169 4,752 (49) 124 75 399 (49) 124 (743) (668) 9,269 317 (7) (8,25) 124 (7,816) 187,21 317 (7) (8,25) 124 (7,816) 187,21 183 183 7,264 214 3 31 213 214 3 31 213 214 3 31 6 Santen Pharmaceutical Co., Ltd. Annual Report 215 7,81 7,776 (2) 463 463 15,516 2,162 2,236 2,236 183 183 7,959 (7) (7) (8,25) 743 (7,57) 162,727 (463) (463) (28) (28) 4,118 4,752 4,752 324 2,486 167,857 27,169 167,857 27,169 4,752 (49) 124 75 399 (49) 124 (743) (668) 9,269 317 (7) (8,25) 124 (7,816) 187,21 317 (7) (8,25) 124 (7,816) 187,21 183 183 7,264 214 3 31 213 214 3 31 213 214 3 31
61 Santen Pharmaceutical Co., Ltd. Annual Report 215 214 4 1 7,264 7,959 162,727 24,32 24,32 33 33 4,118 7,863 7,863 118 118 8,77 (18) (8,259) 34 (7,919) 178,84 (33) (33) (37) (37) 11,944 215 3 31 214 4 1 4,752 248 248 399 9,269 187,21 24,32 32,446 187,21 24,32 32,446 5, (32) 186 154 553 (32) 186 (34) (186) 17,497 2 (8,259) 186 (7,877) 211,779 25 (8,259) 186 (7,877) 211,779 215 3 31 119 119 7,383 215 3 31 61 Santen Pharmaceutical Co., Ltd. Annual Report 215 214 4 1 7,264 7,959 162,727 24,32 24,32 33 33 4,118 7,863 7,863 118 118 8,77 (18) (8,259) 34 (7,919) 178,84 (33) (33) (37) (37) 11,944 215 3 31 214 4 1 4,752 248 248 399 9,269 187,21 24,32 32,446 187,21 24,32 32,446 5, (32) 186 154 553 (32) 186 (34) (186) 17,497 2 (8,259) 186 (7,877) 211,779 25 (8,259) 186 (7,877) 211,779 215 3 31 119 119 7,383 215 3 31
215 3 31 214 4 1 $6,449 $66,227 $(78) $1,354,141 199,985 199,985 $ $34,264 2,524 65,442 2,524 65,442 99 99 (8) (68,732) 215 3 31 99 $61,439 99 $67,217 (8) $(158) 2,833 (65,899) $1,488,227 (2,524) (2,524) $ (39) (39) $99,397 214 4 1 $39,548 2,6 2,6 $3,322 $ 77,134 7,26 7,26 $1,557,873 199,985 7,26 27,11 $1,557,873 199,985 7,26 27,11 215 3 31 $41,68 (267) 1,545 1,278 $4,6 (267) 1,545 (2,833) (1,555) $145,65 1,713 (8) (68,732) 1,545 (65,554) $1,762,33 1,713 (8) (68,732) 1,545 (65,554) $1,762,33 62 Santen Pharmaceutical Co., Ltd. Annual Report 215
63 Santen Pharmaceutical Co., Ltd. Annual Report 215 215 3 31 215 $199,985 57,899 2,413 (4,46) 98,452 (64,88) (4,332) 1,48 6,336 21,258 323,925 (73) 1,53 (945) 34,53 (24,734) 5,455 (528,155) (492) (513,514) 673 4,562 (682) (117,23) 211,248 214 215 2,841 216 (759) 1,643 (8,128) 1,411 5,242 346 1,883 33,413 24,32 6,958 29 (529) 11,831 (7,71) (521) 1,251 761 2,554 38,926 (111) 92 (4,825) 2,933 (3,461) 2 (2,418) (59) (7,847) (84) 184 (114) 4,149 (2,972) 656 (63,468) (6) (61,79) 14 518 (7,34) 26,686 81 548 (82) (14,87) 25,386 291,254 (291,254) 332,862 (24,712) (68,769) 1,67 24,988 (61,278) 62,451 7,48 $548,581 (29) (8,247) 322 (7,954) 1,885 6,237 1,275 72,397 35, (35,) 4, (2,97) (8,264) 194 28,96 (7,363) 72,397 889 65,923 63 Santen Pharmaceutical Co., Ltd. Annual Report 215 215 3 31 215 $199,985 57,899 2,413 (4,46) 98,452 (64,88) (4,332) 1,48 6,336 21,258 323,925 (73) 1,53 (945) 34,53 (24,734) 5,455 (528,155) (492) (513,514) 673 4,562 (682) (117,23) 211,248 214 215 2,841 216 (759) 1,643 (8,128) 1,411 5,242 346 1,883 33,413 24,32 6,958 29 (529) 11,831 (7,71) (521) 1,251 761 2,554 38,926 (111) 92 (4,825) 2,933 (3,461) 2 (2,418) (59) (7,847) (84) 184 (114) 4,149 (2,972) 656 (63,468) (6) (61,79) 14 518 (7,34) 26,686 81 548 (82) (14,87) 25,386 291,254 (291,254) 332,862 (24,712) (68,769) 1,67 24,988 (61,278) 62,451 7,48 $548,581 (29) (8,247) 322 (7,954) 1,885 6,237 1,275 72,397 35, (35,) 4, (2,97) (8,264) 194 28,96 (7,363) 72,397 889 65,923
http://www.santen.co.jp/ja/ir/document/securities.jsp 64 Santen Pharmaceutical Co., Ltd. Annual Report 215